Ventyx biosciences to participate in the oppenheimer 34th annual healthcare life sciences conference

San diego, feb. 06, 2024 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx) (“ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that company executives will participate in the upcoming oppenheimer 34th annual healthcare life sciences conference.
VTYX Ratings Summary
VTYX Quant Ranking